NDC 72187-0102 – Orserdu

Elacestrant 345 mg/1 · Tablet, Film Coated · Oral

Human Prescription Drug

Product NDC72187-0102

Product details

Brand name
Orserdu
Generic name
Elacestrant
Labeler
Stemline Therapeutics, Inc.
Dosage form
Tablet, Film Coated
Route
Oral
Marketing category
NDA · NDA217639
Marketed since
January 27, 2023
Listing expires
December 31, 2027
Pharmacologic class
Estrogen Receptor Antagonist

Active ingredients

Uses, dosage, side effects and warnings for Orserdu →

Package NDC codes (1)

Package NDCDescriptionSince
72187-0102-330 TABLET, FILM COATED in 1 BOTTLE (72187-0102-3)Jan 27, 2023

Other Orserdu products